INDV FY 2021 Earnings — Indivior Pharmaceuticals Inc Revenue & Financial Results | Market Cap Arena

INDVIndivior Pharmaceuticals Inc

$4B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$791M+22.3% YoY

Gross Profit

$664M83.9% margin

Operating Income

$213M26.9% margin

Net Income

$205M25.9% margin

EPS (Diluted)

$1.31

Cash Flow

Operating Cash Flow

$353M

Free Cash Flow

$319M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.6B

Stockholders' Equity

$203M

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$791M	$647M	+22.3%
Gross Profit	$664M	$550M	+20.7%
Operating Income	$213M	-$156M	+236.5%
Net Income	$205M	-$148M	+238.5%